Guided Therapeutics Inc. (OTCMKTS:GTHP) Sees Large Increase in Short Interest

Guided Therapeutics Inc. (OTCMKTS:GTHP) was the target of a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 3,028 shares, an increase of 113.8% from the July 30th total of 1,416 shares. Based on an average trading volume of 5,999 shares, the short-interest ratio is currently 0.5 days. Approximately 0.0% of the company’s stock are sold short.

Guided Therapeutics Stock Performance

Shares of OTCMKTS GTHP opened at $0.23 on Monday. The firm has a market cap of $22.40 million, a PE ratio of -5.80 and a beta of 0.71. Guided Therapeutics has a 1-year low of $0.15 and a 1-year high of $0.54. The company has a fifty day moving average price of $0.27 and a 200 day moving average price of $0.26.

Guided Therapeutics (OTCMKTS:GTHP) last released its earnings results on Thursday, August 13th. The company reported ($0.01) earnings per share (EPS) for the quarter.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non?invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.

The company secured 510(k) clearance from the U.S.